miR-107 enhances the sensitivity of breast cancer cells to paclitaxel
Breast cancer remains the most commonly diagnosed cancer in Chinese women. Paclitaxel (PTX) is a chemotherapy medication used to treat breast cancer patients. However, a side effect of paclitaxel is the severe drug resistance. Previous studies demonstrated that dysregulation of microRNAs could regul...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
De Gruyter
2019-06-01
|
| Σειρά: | Open Medicine |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1515/med-2019-0049 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|